TEB vs PVB In reducing chronic post thoracotomy pain

  • Research type

    Research Study

  • Full title

    A randomised controlled trial to investigate the effectiveness of ThOracic epidural and Paravertebral blockade In reducing Chronic post-thoracotomy pain - TOPIC Feasibility Study

  • IRAS ID

    163096

  • Contact name

    Fang Gao

  • Contact email

    f.g.smith@bham.ac.uk

  • Sponsor organisation

    Heart of England NHS Foundation trust

  • Duration of Study in the UK

    2 years, 0 months, 1 days

  • Research summary

    Surgery through the side of the chest (thoracotomy), usually to treat lung
    cancer, causes pain post-operatively, with more than a half of patients
    developing chronic post-thoracotomy pain (CPTP) which can last months
    or years. This pain can be severe and debilitating, leading to more frequent
    GP visits, longer sick leave or even unemployment. CPTP will remain a
    significant health care and economic burden as there has been an
    increase in lung operations over the last decade of around 60%, and the
    trend is likely to continue. Thoracic epidural blockade (TEB), numbing
    nerves on both sides of the chest, and paravertebral blockade (PVB),
    targeting pain relief to the side of the surgery are two common techniques
    that provide good pain relief. But crucially, there is evidence that PVB may
    reduce the likelihood of chronic pain developing afterwards because of its
    different sites of action from TEB. Previous trials directly comparing TEB
    and PVB have not examined chronic pain as the main outcome, and were
    methodologically flawed, thereby failing to reliably evaluate the two
    techniques. We seek to investigate clinical and cost effectiveness of PVB
    on CPTP in a well-designed randomised trial. Our team, with the expertise
    needed and strong support from the community of thoracic surgeons,
    anaesthetists and patients, is uniquely placed to run this critically important
    study. However there are certain aspects of the trial that need further
    clarification-such as how many patients will consent to being randomised
    to PVB or TEB? Which factors motivate, or become barriers for clinicians
    and patients to agree to be randomised? Are there any technical difficulties
    that need to be overcome in order to conduct a full trial? This pilot study
    aims to answer these questions so that the subsequent randomised
    controlled trial has the best chance of gaining funding and being
    successful.

  • REC name

    East Midlands - Derby Research Ethics Committee

  • REC reference

    14/EM/1280

  • Date of REC Opinion

    24 Dec 2014

  • REC opinion

    Further Information Favourable Opinion